Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Team.

Lancet. 2009 Jun 20;373(9681):2125-35. doi: 10.1016/S0140-6736(09)60953-3. Epub 2009 Jun 6.

PMID:
19501900
[PubMed - indexed for MEDLINE]
2.

Glutamic acid decarboxylase and islet cell antibodies in healthy Estonian children.

Adojaan B, Sabbah E, Vähäsalo P, Akerblom HK, Podar T, Knip M.

J Pediatr Endocrinol Metab. 1999 Sep-Oct;12(5):667-72.

PMID:
10703539
[PubMed - indexed for MEDLINE]
3.

Seasonal variation in the incidence of Type 1 diabetes mellitus during 1983 to 1992 in the countries around the Baltic Sea.

Padaiga Z, Tuomilehto J, Karvonen M, Dahlquist G, Podar T, Adojaan B, Urbonaite B, Zalinkevicius R, Brigis G, Virtala E, Kohtamäki K, Cepaitis Z, Tuomilehto-Wolf E.

Diabet Med. 1999 Sep;16(9):736-43.

PMID:
10510949
[PubMed - indexed for MEDLINE]
4.

Distribution of insulin-dependent diabetes mellitus (IDDM)-related HLA alleles correlates with the difference in IDDM incidence in four populations of the Eastern Baltic region.

Nejentsev S, Koskinen S, Sjöroos M, Reijonen H, Schwartz EI, Kovalchuk L, Sochnev A, Adojaan B, Podar T, Knip M, Simell O, Koskenvuo M, Akerblom HK, Ilonen J.

Tissue Antigens. 1998 Nov;52(5):473-7.

PMID:
9864037
[PubMed - indexed for MEDLINE]
5.

The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302.

Nejentsev S, Reijonen H, Adojaan B, Kovalchuk L, Sochnevs A, Schwartz EI, Akerblom HK, Ilonen J.

Diabetes. 1997 Nov;46(11):1888-92.

PMID:
9356041
[PubMed - indexed for MEDLINE]
6.

HLA-DQB1*0304-DRB1*0408 haplotype associated with insulin-dependent diabetes mellitus in populations in the eastern Baltic region.

Ilonen J, Koskinen S, Nejentsev S, Sjöroos M, Knip M, Schwartz EI, Adojaan B, Kovalchuk L, Sochnevs A.

Tissue Antigens. 1997 May;49(5):532-4.

PMID:
9174152
[PubMed - indexed for MEDLINE]
7.

Relationship between the incidence of childhood IDDM and the frequency of ICA positivity in nondiabetic children in the general population.

Adojaan B, Knip M, Vähásalo P, Karjalainen J, Kalits I, Akerblom HK.

Diabetes Care. 1996 Dec;19(12):1452-4. No abstract available.

PMID:
8941485
[PubMed - indexed for MEDLINE]
8.

Physical development in Estonian children with type 1 diabetes.

Tillmann V, Adojaan B, Shor R, Price DA, Tuvemo T.

Diabet Med. 1996 Jan;13(1):97-101.

PMID:
8741820
[PubMed - indexed for MEDLINE]
9.

Comparison of the incidence of insulin-dependent diabetes mellitus in childhood among five Baltic populations during 1983-1988.

Tuomilehto J, Podar T, Brigis G, Urbonaite B, Rewers M, Adojaan B, Cepaitis Z, Kalits I, King H, LaPorte R, et al.

Int J Epidemiol. 1992 Jun;21(3):518-27.

PMID:
1634314
[PubMed - indexed for MEDLINE]
10.

Insulin-dependent diabetes mellitus in native Estonians and immigrants to Estonia.

Podar T, Tuomilehto-Wolf E, Tuomilehto J, LaPorte RE, Adojaan B.

Am J Epidemiol. 1992 Jun 1;135(11):1231-6.

PMID:
1385671
[PubMed - indexed for MEDLINE]
11.

Comparison of incidence of IDDM in childhood between Estonia and Finland, 1980-1988.

Tuomilehto J, Podar T, Reunanen A, Kalits I, Lounamaa R, Tuomilehto-Wolf E, Adojaan B, Neff B, LaPorte RE.

Diabetes Care. 1991 Nov;14(11):982-8.

PMID:
1797512
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk